Literature DB >> 26426305

Oncologic Outcomes according to the Treatment Strategy in Radiologic Complete Responders after Neoadjuvant Chemoradiation for Rectal Cancer.

Soo Young Lee1, Chang Hyun Kim, Young Jin Kim, Hyeong Rok Kim.   

Abstract

OBJECTIVE: This study aimed to compare the oncologic outcomes between treatment strategies for rectal cancer [radical surgery, local excision (LE), and the wait-and-see approach] in radiologic complete responders after neoadjuvant chemoradiation (nCRT).
METHODS: We retrospectively reviewed rectal cancer patients and included 52 radiologic complete responders after nCRT defined as no residual tumor or residual fibrosis and no suspicious metastatic lymph nodes on magnetic resonance imaging (MRI). Clinicopathologic features and oncologic outcomes were compared according to the treatment strategies.
RESULTS: The median follow-up period was 41 months (range, 6-80). Twenty-eight patients underwent radical surgery, whereas 16 underwent LE, and 8 were closely monitored without initial surgery. The pathologic complete response rate was 40.9%. Patients who underwent radical surgery showed better prognosis compared to those who underwent LE or wait-and-see (3-year disease-free survival: radical surgery 85.0% vs. LE 62.5%, wait-and-see 75.0%, p = 0.019; 3-year local recurrence-free survival: radical surgery 96.4% vs. LE 67.0%, wait-and-see 75.0%, p = 0.009). After recurrence, patients who underwent salvage surgery showed a relatively good oncologic outcome.
CONCLUSION: Pursuing LE or the wait-and-see approach instead of radical surgery in rectal cancer patients undergoing nCRT may bring about a detrimental oncologic outcome if clinical complete response is solely determined by MRI.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26426305     DOI: 10.1159/000439279

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  7 in total

1.  Wait and see approach for rectal cancer with a clinically complete response after neoadjuvant concurrent chemoradiotherapy.

Authors:  Hyun Jung Kim; Jin Ho Song; Hyeong Sik Ahn; Bong-Hoi Choi; Hojin Jeong; Hoon Sik Choi; Yun Hee Lee; Ki Mun Kang; Bae Kwon Jeong
Journal:  Int J Colorectal Dis       Date:  2016-11-24       Impact factor: 2.571

2.  Nonoperative Management or 'Watch and Wait' for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal.

Authors:  Tarik Sammour; Brandee A Price; Kate J Krause; George J Chang
Journal:  Ann Surg Oncol       Date:  2017-03-21       Impact factor: 5.344

3.  Efficacy and safety of the "watch-and-wait" approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis.

Authors:  Xuan Zhang; Rong Ding; JinSha Li; Tao Wu; ZhengHai Shen; ShanShan Li; Ya Zhang; Chao Dong; ZhongJun Shang; Hai Zhou; Ting Li; GuoYu Li; YunFeng Li
Journal:  Surg Endosc       Date:  2022-01-03       Impact factor: 4.584

Review 4.  Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.

Authors:  Jun Li; Lunjin Li; Lin Yang; Jiatian Yuan; Bo Lv; Yanan Yao; Shasha Xing
Journal:  Oncotarget       Date:  2016-07-12

5.  Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.

Authors:  Heera Yoen; Hye Eun Park; Se Hyung Kim; Jeong Hee Yoon; Bo Yun Hur; Jae Seok Bae; Jung Ho Kim; Hyeon Jeong Oh; Joon Koo Han
Journal:  Korean J Radiol       Date:  2020-09       Impact factor: 3.500

6.  Prognosis comparison between wait and watch and surgical strategy on rectal cancer patients after treatment with neoadjuvant chemoradiotherapy: a meta-analysis.

Authors:  Kai Pang; Quan Rao; Shengqi Qin; Lan Jin; Hongwei Yao; Zhongtao Zhang
Journal:  Therap Adv Gastroenterol       Date:  2019-12-03       Impact factor: 4.409

7.  Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis.

Authors:  Guo-Hua Zhao; Li Deng; Dong-Man Ye; Wen-Hui Wang; Yan Yan; Tao Yu
Journal:  World J Surg Oncol       Date:  2020-08-31       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.